ScoreWhy is Pharming Group NV ?
1
Weak Long Term Fundamental Strength with a -15.26% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.32
2
With ROE of 0.57%, it has a Expensive valuation with a 4.41 Price to Book Value
- Over the past year, while the stock has generated a return of 67.33%, its profits have risen by 107% ; the PEG ratio of the company is 7.2
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pharming Group NV for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Pharming Group NV
71.14%
0.30
57.88%
Netherlands AEX
5.05%
0.38
14.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.67%
EBIT Growth (5y)
-15.26%
EBIT to Interest (avg)
-0.32
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.60
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.16%
ROE (avg)
7.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
768
Industry P/E
Price to Book Value
4.41
EV to EBIT
43.38
EV to EBITDA
28.76
EV to Capital Employed
4.66
EV to Sales
2.69
PEG Ratio
7.18
Dividend Yield
NA
ROCE (Latest)
10.74%
ROE (Latest)
0.57%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Pharming Group NV
Inventory Turnover Ratio- Half Yearly
Highest at 4.61 times
in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Pharming Group NV
Interest - Half-Yearly
At EUR 5.62 MM has Grown at 148.69 %
over previous YearMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (EUR MM)
Profit After Tax (PAT) - Quarterly
At EUR -11 MM has Fallen at -430.0 %
over average PAT of the previous four periods of EUR -2 MMMOJO Watch
Near term PAT trend is very negative
PAT (EUR MM)
Operating Cash Flow - Annually
Lowest at EUR -19.55 MM and Fallen
each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (EUR MM)
Net Sales - Quarterly
At EUR 51 MM has Fallen at -9.7 %
over average Net Sales of the previous four periods of EUR 57 MMMOJO Watch
Near term sales trend is very negative
Net Sales (EUR MM)
Operating Profit to Interest - Quarterly
Lowest at -6.90 times
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest (EUR MM)
Profit After Tax (PAT) - Quarterly
Lowest at EUR -11 MM.
in the last five periodsMOJO Watch
Near term PAT trend is negative
PAT (EUR MM)
Earnings per Share (EPS) - Quarterly
Lowest at EUR -0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (EUR)
Cash and Cash Equivalents - Half Yearly
Lowest at EUR 48.05 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents (EUR MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
